Study Evaluating the Tolerability of Bifeprunox in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

144

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Healthy

Interventions

DRUG

bifeprunox

oral tablet once daily

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00581451 - Study Evaluating the Tolerability of Bifeprunox in Healthy Subjects | Biotech Hunter | Biotech Hunter